| CASE REPORT |
|
| Year : 2017 | Volume
: 3
| Issue : 2 | Page : 122-124 |
|
|
Eight months of HeartMate II device support without drug therapy
Kewal Krishan1, Sean Pinney2, Anelechi C Anyanwu1
1 Department of Cardiothoracic Surgery, Mount Sinai Medical Center, New York, NY 10029, USA
2 Mount Sinai Heart, Mount Sinai Medical Center, New York, NY 10029, USA
Correspondence Address:
Anelechi C Anyanwu
Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Avenue, New York, NY 10029
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpcs.jpcs_30_17
|
|
|
Thromboembolic complication rates of 20%–30% were initially a major limitation to the widespread use of left ventricular assist devices. The success of the HeartMate (Thoratec, Corp., Pleasanton, CA, USA) device has been partly due to the reduced incidence of thromboembolic events, although anticoagulation regime has been recommended for this mechanical circulatory support. We here present a case with the placement of HeartMate II in a patient, noncompliant to medical therapy where device worked for 8 months without any anticoagulant or antiplatelet therapy.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
